Amos Meltzer

Amos Meltzer is a seasoned executive with extensive experience in the biopharmaceutical and healthcare technology sectors. Currently serving as Chief Operating Officer at Synchron since May 2015, Meltzer focuses on advanced neural interface technologies. Leadership roles include Chairman of the Board at Maverick Bio, Non-Executive Director at Paradigm Biopharmaceuticals, and Principal at BioMeltzer. Previous positions include non-executive director roles at Cannatrek and Vasculab Pty Limited, where Amos contributed to vascular medicine training and education. Prior to this, Meltzer was CEO of Immuron Limited, a biopharmaceutical company specializing in oral immunotherapy. His legal background encompasses roles at KL Gates, Compugen Ltd., and Evogene Ltd. Meltzer holds multiple degrees from the University of Melbourne, including a Bachelor of Agricultural Science (Hons), a Bachelor of Laws, and a Graduate Diploma in Intellectual Property.